| WELCOME |
| The research in the laboratory is directed towards elucidating the role of calmodulin in several signal transduction pathways. Novel calmodulin targets are studied. The major areas of interest are the disruption of the normal signaling pathways that result in breast cancer. A diverse Array of biochemical, cell biological, and molecular biological approaches are used in these investigations. |
|
| ABOUT DR. SACKS |
Dr. David B. Sacks is the Principal Investigator
|
 Associate Professor of Pathology
Harvard Medical School |
 Medical Director of Clinical Chemistry
Director, Clinical Pathology Residency Program
Brigham and Women's Hospital |
| Complete Curriculum Vitae Click Here |
| |
|
|
